Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-ketamine and lidocaine for prevention of perioperative neurological dysfunction and chronic pain in thoracoscopic lung surgery
ChiCTR2100045459Phase 4Recruiting
- Sponsor
- The Affiliated Hospital of Yangzhou University
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine and lidocaine in bronchial carcinoma and pulmonary tuberculosis (TB) (3 arms), sponsored by The Affiliated Hospital of Yangzhou University. Primary endpoint: Postoperative consumption of analgesics. Started Mar 2021; status: recruiting.
02
Drugs
esketaminelidocaine
03
Conditions
bronchial carcinomapulmonary tuberculosis (TB)
Beyond the preview
Go deeper on ChiCTR2100045459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100045459.